• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Video

August 3, 2021

Expert: Data from Opioid-Related Activities in Academic Pharmacy Show the Value of Pharmacists’ Efforts to Fight the Opioid Epidemic

Conference|AACP Annual Meeting - American Association of Colleges of Pharmacy Annual Meeting

Thomas Maggio, MBA, public affairs and engagement manager at AACP, discussed his presentation assessing the Opioid-Related Activity Database and its impact in showing the efforts of pharmacists and student pharmacists to fight the opioid epidemic.

Pharmacy Times interviewed Thomas Maggio, MBA, public affairs and engagement manager at American Association of Colleges of Pharmacy (AACP), to discuss his presentation titled Opioid-Related Activities in Academic Pharmacy at the AACP 2021 conference.

Alana Hippensteele: What is the Opioid-Related Activity Database, and why was it launched?

Thomas Maggio: The AACP launched the database because the opioid epidemic is a significant health crisis that's affecting all communities, and we noticed that there was no unified collection of relevant activities undertaken by academic pharmacy.

The database itself is a collection of opioid-related activities being conducted at all colleges and schools of pharmacy across the country, and the purpose is to inform the pharmacy profession and other stakeholders about these efforts and provide direction and insight to those looking to launch their own activities to address the opioid epidemic.

It started in July of 2018, that's when AACP made the official call to our member colleges at schools of pharmacy to share information on all opioid-related activities that they're conducting. By the fall of 2018, we received over 415 submissions. After we receive all those submissions, a team of AACP staff members and volunteer members from the substance use disorder special interest group began coding those submissions.

So, coding involved putting each activity into multiple categories, those categories are education, research, service, practice, and advocacy. Then AACP also developed 50 plus tags to refine the coding process.

Finally, in February of 2019, AACP launched the searchable opioid-related activity database with all those activities included.

Alana Hippensteele: What are some of the activities at pharmacy schools that the database was able to highlight?

Thomas Maggio: We've highlighted multiple activities in our executive summaries, in our database poster that we share at meetings, and then in other publications.

Some good examples are from Ohio Northern University. They direct a mobile clinic that provides an entry point into the health care system for people at risk for substance abuse and those with behavioral health concerns among the medically underserved communities in their area.

By using a multidisciplinary team of student health care providers under the supervision of a licensed professional, this project was able to provide initial assessment, intervention, referral, and follow-up care for these communities.

Regarding the opioid epidemic specifically, the mobile clinic had 4 goals. The goals were to provide an entry into the health care system for the underserved people in the area, connect individuals with substance abuse and behavioral health concerns to specialized treatment services, provide case management following initial substance abuse and behavioral health treatment to improve treatment adherence and reduce disease reoccurrence, and then finally to provide preventative health education on substance abuse to junior and senior high school students and the general public in that area.

Another activity that we wanted to highlight was by the University of Texas at Austin, which we included in our 2020 executive summary. We highlighted it because at the end of the activity, it provided statistical results of the direct impact that the activity had.

The University of Texas at Austin, they're a primary provider of statewide opioid overdose prevention training, as well as naloxone distribution in Texas. It also provides continuing education for health care professionals.

So, through this opioid overdose prevention training, about 1900 Texans have been trained to prevent overdose, 20,000 doses of naloxone have been distributed, and 146 successful overdose reversals have been reported, although the number with the actual is probably likely higher. Additionally, through online continuing education, 767 pharmacists and technicians, 62 physicians and other prescribers, and 146 behavioral health professionals have been trained.

Then the last activities that we want to highlight, it's more of a broader group of activities, and those are the ones that we have tagged with Generation Rx. So, these activities are vital because it shows the impact that student pharmacists and future pharmacist practitioners have on the opioid epidemic, and currently there are about 27 Generation Rx activities in the database.

Alana Hippensteele: Wow, that's amazing. What kind of research has been conducted to understand and assess some of this data that has been compiled through the database?

Thomas Maggio: Multiple research points provide insight into the database. So, at AACP, I keep track of a variety of statistics as we add new activities.

Those statistics range from category breakdown, activity count, tag count, whether the institution is public versus private, the program type as to whether it's traditional or accelerated, and then activities per institution we also keep track of.

Then in addition to that, a group of AACP members have been working on a research paper regarding the database. So, this is that same group of members from the substance use disorder that helped label with the initial coding.

So, their goal for the manuscript is to provide an in-depth qualitative analysis of the 5 main categories, which were education, research, service practices, and advocacy, as well as identify strengths, gaps, and additional needs of academic pharmacy programs based on the reported activities in the database.

Then finally, they want to inform a manuscript for AJPE detailing the findings, the implications, and the steps for meeting needs identified through the analysis. Then one last thing, as far as the research goes, several student pharmacists have conducted research utilizing the database. So, these student pharmacists presented their training abstracts at the AACP annual meeting in 2020 and 2021.

Alana Hippensteele: What were some of the findings of some of this research? I know that there's been a wide array of focuses, but are there any findings of the research analyzing this data that might be good to highlight?

Thomas Maggio: Sure. So, I'll break that down into 2 categories: the statistical findings that AACP does and the findings that that research team found.

So, currently there's about 467 activities in the database, so it has continually grown since the initial launch. I know we saw a slew of activity submitted during last year because of COVID-19, but hopefully we're going to start seeing an uptick in submissions.

As far as the category breakdown goes, so activities can fall into multiple categories, they don't just have to fall into one, so they can be education and service. So, in total, we have 305 education activities, 118 research, 112 service, 34 practice, and 17 advocacy.

We also have activities represented in 45 states, including DC and Puerto Rico. It was a pretty even split of public schools versus private schools. We have 56 public and 58 private, and then we have a 104 traditional programs represented, a 100 traditional programs represented, and 14 accelerated programs.

Then, as far as the tags go, we have 50 tags. I’ll go through the top 5 that I used. We have student pharmacists, substance use disorder, naloxone, didactic, and then substance use disorder treatment.

So, some of the emergent findings from the paper were using these strengths gaps and needs, finding what those are. So, they found that the strengths lie in education in activities that were interprofessional and community-based. Under community service, naloxone access and drug disposal was found to be a strength, and then also just overall through the database partnerships with local health departments.

Some gaps that were identified were harm reduction beyond naloxone. So, we tagged any service activity that was categorized service that had naloxone was also tagged with harm reduction because that is the ultimate goal of that. But a gap was harm reduction beyond naloxone tags.

Another gap was experiential education opportunities and community-based research and practice. Then finally, the needs were schools need resources for advanced training, and then policy changes to enable pharmacists to play a substantial role in harm reduction.

Alana Hippensteele: Okay, and why are some of these findings important to academic pharmacy more broadly speaking?

Thomas Maggio: The strengths gaps and needs all provide findings for academic pharmacy. The strengths show that activities that are prevalent in the database, so institutions that may be lacking in these types of activities—they can use the database for direction and insight. The gaps and needs show where there is room for improvement.

However, knowing these gaps and needs is beneficial because it allows colleges and schools of pharmacy, as well as AACP, to focus their efforts to address them in the future. These findings also provide opportunities for collaboration between colleges and schools of pharmacy within their own state and showcase the role of student pharmacists to help combat the opioid crisis in their community.

Alana Hippensteele: How could the research findings potentially impact the future of how pharmacy schools approach opioid-related activities in the academic sector?

Thomas Maggio: So, research findings can only help. It shows the value that colleges and schools of pharmacies bring to their communities and the impact of the work and efforts of the student pharmacists. Knowing they're addressing an issue and that it is working will only grow confidence in student pharmacists and show the value that pharmacists have across the country.

The gaps in needs identify areas of growth to continue providing additional training to student pharmacists and practicing pharmacists, as well as educating the communities. So, by addressing these, they'll be able to expand their programs and reach their communities in a way that they haven't been able to in the past.

Alana Hippensteele: Yeah, thank you so much for taking the time to speak with me today, Thomas.

Thomas Maggio: Oh no problem, thank you.

Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Focuses on medical shield icon with healthcare symbols like hospital, Health Insurance and Medical Care Concept. doctor, medicine, and emergency care - Image credit: Jim | stock.adobe.com
May 13th 2025

May 2025 Pharmacy Policy

Aislinn Antrim, Managing Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
cruciferous vegetables capsules, dietary supplements for healthy - Image credit: SewcreamStudio | stock.adobe.com
May 13th 2025

Research Suggests Natural Supplementation Could Decrease Biological Age

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Pregnant woman having her blood pressure taken -- Image credit: didesign | stock.adobe.com
May 12th 2025

Children Born to Mothers With Cardiometabolic Issues Before or During Pregnancy Face Increased Risk of Childhood, Adolescent Hypertension

Gillian McGovern, Associate Editor
Ozempic, Mounjaro and Wegovy injectable pens on white background - Image credit: K KStock | stock.adobe.com
May 12th 2025

Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight Management

Emilie Collongette, PharmD, CPh, BCMTMS Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Focuses on medical shield icon with healthcare symbols like hospital, Health Insurance and Medical Care Concept. doctor, medicine, and emergency care - Image credit: Jim | stock.adobe.com
May 13th 2025

May 2025 Pharmacy Policy

Aislinn Antrim, Managing Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
cruciferous vegetables capsules, dietary supplements for healthy - Image credit: SewcreamStudio | stock.adobe.com
May 13th 2025

Research Suggests Natural Supplementation Could Decrease Biological Age

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Pregnant woman having her blood pressure taken -- Image credit: didesign | stock.adobe.com
May 12th 2025

Children Born to Mothers With Cardiometabolic Issues Before or During Pregnancy Face Increased Risk of Childhood, Adolescent Hypertension

Gillian McGovern, Associate Editor
Ozempic, Mounjaro and Wegovy injectable pens on white background - Image credit: K KStock | stock.adobe.com
May 12th 2025

Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight Management

Emilie Collongette, PharmD, CPh, BCMTMS Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.